Background: In our practice, we noticed that patients respond differently when pacemaker insertion is recommended to them. We then saw the need to study how African patients accept elective pacemaker implantation.
Aim: The study was conducted to determine African patients' responses to elective pacemaker insertion.
Patients And Methods: We recruited patients who reported at our outpatient clinic with indications for elective pacemaker insertion. The study period lasted 64 months from September 1999. The patients were counseled before insertion and we sought their consent before being recruited for the study. Five possible responses were used to grade acceptance. They were followed up for 12 months each. Patients who were brought in emergency and those who refused participation were excluded. Those who missed follow-up were also dropped.
Results: Ninety-two patients (n = 92) met our study criteria after dropping eight patients who missed follow-up clinic attendance. Most of the candidates (71.7%) felt they had no options but to accept pacemakers at the time of operation. The remaining candidates either accepted the procedure with hope or wholeheartedly. Most of the candidates migrated up the ladder of acceptance over the 12-month period.
Discussion And Conclusion: We concluded that most patients would accept pacemakers wholeheartedly over time.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1540-8159.2011.03228.x | DOI Listing |
Cureus
December 2024
Cardiology, Wright State University Boonshoft School of Medicine, Dayton, USA.
Permanent pacemaker (PPM) implantation is the standard of care in patients with complete heart block (CHB) and second-degree type II atrioventricular (AV) block irrespective of patient symptoms when the conduction abnormality is irreversible. CHB generally constitutes a medical emergency that can be fatal if not urgently treated. This is in contrast to first-degree AV block and second-degree type I AV block, which require PPM implantation only in very special circumstances.
View Article and Find Full Text PDFInnovations (Phila)
December 2024
Heart Center, Department of Cardiovascular Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), China.
Objective: This study aims to assess the safety, efficacy, and esthetic outcomes of an innovative 4 cm right infra-axillary incision approach for concomitant ascending aorta and aortic valve replacement (AAR and AVR), with a specific focus on achieving optimal surgical outcomes while ensuring minimal visible scarring.
Methods: We retrospectively examined all elective cases of concomitant AAR and AVR surgery performed at our institution from July 2021 to June 2023. Exclusions encompassed emergency surgery, acute type A aortic dissection, active aortic valve endocarditis, redo cardiac surgery, the necessity for concurrent mitral valve replacement, or left ventricular assist device implantation.
Ann Thorac Surg
February 2025
Division of Cardiac Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Background: Conduction abnormalities requiring permanent pacemaker (PPM) implantation are common after tricuspid valve operations, although the incidence is variable. This study investigated contemporary rates of and risk factors for a PPM after tricuspid operations.
Methods: The Society of Thoracic Surgeons Adult Cardiac Surgery Database was used to identify patients with tricuspid repair or replacement from 2011 to 2020.
Europace
October 2024
Cardiology Department, Na Homolce Hospital, Roentgenova 37/2, 15030 Prague, Czech Republic.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!